IL6 and rheumatoid arthritis: In addition, another IL‐6R human monoclonal antibody, Sarilumab, and an IL‐6 monoclonal antibody, Sirukumab, also shown therapeutic effects in RA, as demonstrated in the MOBILITY study.165